Xi'an Tianlong Science and Technology

What Xi'an Tianlong Science and Technology does

Xi'an Tianlong Science and Technology Co., Ltd. (天隆科技) is a privately held Chinese in vitro diagnostics manufacturer founded in 1997 and headquartered in the Economic & Technological Development Zone of Xi'an, Shaanxi Province. The company designs, develops, and manufactures molecular diagnostics instruments and reagents, with a portfolio spanning nucleic acid extractors (GeneRotex 96, Aurora PANA X6), real-time PCR systems (Gentier 96E, Gentier X3 Series, Gentier Mini+), all-in-one molecular diagnosis systems (Panall 8000), automated workstations (PANA 9600S, PANA S401, GeneMix Pro), portable point-of-care devices (iGenecase 1600, Biolum ATP Monitoring System Pro), and more than 600 compatible reagent kits covering respiratory infections, sexually transmitted infections, blood screening, viral hepatitis, oncology, maternal and child health, pharmacogenomics, tropical and zoonotic diseases, gastrointestinal infections, animal health, and food safety. The company also offers OEM/ODM services and integrated laboratory solutions such as the Tianlong Smart Lab Solution.

Tianlong sells to clinical diagnostic laboratories, public health and epidemic prevention agencies, blood banks, food safety testing facilities, veterinary laboratories, and scientific research institutions, distributing through direct enterprise sales, an international distributor network spanning more than 100 countries, and an online mall. The company holds more than 300 autonomous intellectual property rights, more than 90 China NMPA approvals, and more than 300 international certifications (including CE, MHRA, and AOAC), and has participated in formulating China's first Nucleic Acid Extraction Equipment Standard and first Fluorescence PCR Equipment Standard. R&D infrastructure includes a postdoctoral innovation center (established 2013) and an academician workstation (established 2017), and the company leads a National Key R&D Program under China's 14th Five-Year Plan.

The business model is primarily hardware sales of instruments paired with recurring revenue from proprietary reagent kits, supplemented by OEM/ODM licensing arrangements. Pricing is not publicly disclosed and is quote-based through direct inquiry. The company maintains strategic technology partnerships with Seegene (Korea), AIT Singapore, Pentabase (Denmark), and KHB (Shanghai Kehua Bio-Engineering), and has signaled adjacent expansion into chemiluminescence immunoassay through the Polaris V150 product announced for 2026 exhibition.

Name

Xi'an Tianlong Science and Technology

Legal name

Xi'an Tianlong Science and Technology Co., Ltd.

Website

https://medtl.net

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

Xi'an Tianlong Science and Technology is a privately held Chinese molecular diagnostics manufacturer founded in 1997, producing PCR instruments, nucleic acid extractors, and over 600 reagent kits for clinical labs, public health agencies, blood banks, food safety, veterinary, and research customers in 100+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (Molecular Diagnostics)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Molecular diagnostics instruments
• Nucleic acid testing systems
• Real-time PCR systems
• In vitro diagnostic reagents
• Automated nucleic acid extractors

Headquarters

HQ city

Xian Shi

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Nucleic Acid Testing Instruments and Systems: Sale of proprietary instruments including nucleic acid extractors, real-time PCR systems, automatic nucleic acid workstations, and all-in-one molecular diagnosis systems. The company designs and manufactures its own instrument portfolio targeting clinical, research, and industrial laboratories.
2. Diagnostic Reagents and Testing Kits: Sale of over 600 compatible kits covering diverse applications including respiratory infections (SARS-CoV-2, influenza), sexually transmitted infections (HPV, HIV), blood screening, viral hepatitis, oncology diseases, maternal and child health, tropical infections, gastrointestinal infections, pharmacogenomics, animal health, and food safety testing.
3. OEM/ODM Services: The company provides original equipment manufacturing and original design manufacturing services for molecular diagnostic products, allowing other companies to customize products under their brand.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Tianlong designs, manufactures, and sells molecular diagnostic instruments and reagent kits for nucleic acid testing. Its portfolio spans automated nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis workstations, portable point-of-care devices, and over 600 compatible reagent kits covering respiratory infections, blood screening, hepatitis, HPV, oncology, pharmacogenomics, animal health, and food safety applications. The company also provides integrated laboratory solutions and OEM/ODM services.

Product overview

Tianlong is an in vitro diagnostic device and PCR diagnostics company offering a broad portfolio of molecular diagnostics products and total solutions. The portfolio spans automated instruments (nucleic acid extractors, real-time PCR systems, automated workstations, all-in-one molecular diagnosis systems, and portable diagnostic devices) alongside over 600 compatible reagent kits covering respiratory infections, sexually transmitted infections, viral hepatitis, blood screening, oncology, maternal and child health, pharmacogenomics, tropical/zoonotic diseases, animal health, food safety, and gastrointestinal infections. Key instrument families include the Panall 8000 (all-in-one molecular diagnosis), Gentier series (real-time PCR), GeneRotex/GeneFlex/Libex (nucleic acid extraction), PANA series (lab automation), and Biolum (ATP hygiene monitoring). Tianlong provides OEM/ODM services and complete laboratory solutions, with products marketed in over 100 countries and regions.

Differentiator

Problem solved

Functional benefit

Brands

• Official Mall: The company's e-commerce platform for purchasing Tianlong diagnostic products.

Products and services

• Panall 8000 All-In-One Molecular Diagnosis System Fully automated molecular diagnosis system integrating sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis in a single walkaway workflow, designed for high-throughput clinical laboratories.
• Panall 8000 All-In-One Molecular Diagnosis System (Open System)
• Gentier 96E Real-Time PCR System
• Gentier X3 Series Real-Time PCR System Real-time PCR system with three independently controlled blocks, allowing users to save time and budget while processing multiple runs concurrently; features 2-second 32-well fluorescence scanning.
• Gentier Mini+ 4 Channels Portable Real-Time PCR System
• GeneRotex 96 Nucleic Acid Extractor
• Aurora PANA X6 Automated Nucleic Acid Extraction System
• Biolum Portable ATP Monitoring System Pro Portable ATP hygiene monitoring system providing rapid and accurate sanitation verification data in 10 seconds per test, with a web-based platform requiring no software downloads.
• iGenecase 1600 Diagnostics-in-a-Suitcase
• PANA 9600S Automatic Nucleic Acid Workstation
• PANA S401 Automated Liquid Handling System
• RBT320 Automatic Brucellosis Detection System
• Nucleic Acid Extraction Kit
• Respiratory Infections Kit
• Blood Screening Kit
• Human Papilloma Virus (HPV) PCR Detection Kit
• Viral Hepatitis Kit
• Sexually Transmitted Infections Kit
• Herpes Viruses Kit
• Monkeypox Virus Nucleic Acid Detection Kit
• Tropical Infections & Zoonoses Kit
• Animal Health Kit
• Pharmacogenomics Kit
• Oncology Diseases Kit
• Maternal and Child Health Kit
• Food Safety Monitoring Kit
• Gastrointestinal Infection Kit
• All-In-One Solution for Nucleic Acid Testing Laboratories
• Tianlong Smart Lab Solution
• Environmental Health Monitoring Solutions
• OEM/ODM Services
• Polaris V150 Chemiluminescence Immunoassay Analyzer Chemiluminescence immunoassay analyzer to be showcased at WHX Bangkok 2026 as part of Tianlong's molecular diagnostics portfolio expansion into immunoassay-based testing.
• Integrated Blood Screening Solution for Transfusion Safety Integrated blood screening solution with high automation, high throughput, and high-sensitivity NAT reagents for early detection of HIV, HBV, and HCV for blood banks and transfusion safety applications.

Quantifiable outcome

• Blood screening solutions with high automation, high throughput, and high-sensitivity NAT reagents for early detection of HIV, HBV, and HCV

Named customers3 records

Segments5 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature9 records

Partnerships

Three partnerships are on record, tiered strategic and core.

• SeegenestrategicTechnology or IntegrationStrategic technology partnership for molecular diagnostics development. Seegene is a leading Korean molecular diagnostics company known for its syndromic testing solutions and multiplex PCR technologies.
• AIT SingaporecoreTechnology or IntegrationPartnership with AIT Singapore for diagnostic technology exchange and collaboration. AIT (Agency for Science, Technology and Research) is Singapore's lead government agency for scientific research and development.
• KHB (Shanghai Kehua Bio-Engineering)coreStrategic or Co-development PartnerComprehensive oncology detection solution partnership. Tianlong and KHB combined their respective strengths in molecular diagnostics and immunoassay to offer comprehensive cancer testing solutions to healthcare providers.

Scale indicators5 records

Recent moves5 records

Expansion highlights7 records

Direct peers

• BGI Genomics: Largest Chinese genomics and molecular diagnostics company offering PCR-based sequencing and IVD reagents for clinical, research, and public health applications across global markets — directly comparable in scale, geography, and product breadth to Tianlong.
• Sansure Biotech: Hunan-based Chinese IVD company specializing in molecular diagnostic kits (infectious diseases, reproductive health, oncology) and automated nucleic acid detection systems, with overlapping PCR instrument-plus-kit portfolio and similar tier-3 hospital go-to-market.
• DAAN Gene: Major Chinese molecular diagnostics firm with broad PCR-based infectious disease, genetic, and oncology reagent menu plus real-time PCR instruments — directly overlaps Tianlong's reagent catalog and clinical lab customer base in China and emerging markets.
• Cepheid (Danaher): Global leader in molecular PCR diagnostics via the GeneXpert system with deep US/EU installed base across clinical and reference laboratories; competes directly with Tianlong in real-time PCR and benchtop molecular systems for infectious disease testing.
• bioMérieux (BioFire): Global in vitro diagnostics leader whose BioFire FilmArray syndromic panels dominate multiplex molecular testing; competes with Tianlong's respiratory infection and zoonotic panels in hospital and reference lab markets worldwide.
• Qiagen: Global provider of sample-preparation technologies and PCR-based test kits for molecular diagnostics and research; directly overlaps Tianlong's nucleic acid extraction reagent and real-time PCR consumables businesses.
• Seegene: Korean molecular diagnostics company specializing in multiplex syndromic PCR technologies and a Tianlong technology partner/competitor; overlapping respiratory, STI, and gastroenteritis multiplex kit portfolios.

Broad incumbents

• Hologic: Diversified women's health and molecular diagnostics company operating the Panther/Panther Fusion automated molecular platform; competes in high-throughput nucleic acid testing markets where Tianlong sells Gentier and Panall 8000 systems.
• Roche Diagnostics: World's largest IVD provider operating cobas real-time PCR and cobas Liat systems across clinical labs; competes broadly with Tianlong's infectious-disease PCR franchise especially in European hospital and blood-bank segments.
• Autobio Diagnostics: Major Chinese clinical diagnostics and IVD manufacturer with broad immunoassay, clinical chemistry, and microbiology portfolio; competes with Tianlong in the Chinese hospital lab market with a larger overall scale and broader menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCY6V7xJQ9XJ4SqeHTZ8vF5A
• Facebookfacebook.com/tianlongtechnology
• LinkedInlinkedin.com/company/admin
• Xx.com/AnTianlong

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xi'an Tianlong Science and Technology